XML 50 R39.htm IDEA: XBRL DOCUMENT v3.21.2
Operating Segments (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Segment reporting          
Revenues $ 214,824 $ 505,288 $ 362,417 $ 1,429,842  
Loss from operations (3,009,645) (2,813,872) (5,243,252) (11,287,661)  
Amortization and depreciation 8,840 17,802 17,739 35,448  
Other income, net 247,835 37,109 118,964 92,671  
Share-based compensation 80,621 81,003 175,426 144,694  
Identifiable Assets 29,610,289   29,610,289   $ 19,891,235
Public Health Solutions          
Segment reporting          
Revenues 214,824 468,009 362,417 1,376,818  
Loss from operations (231,954) (50,737) (362,735) (209,239)  
Amortization and depreciation 311 7,318 627 14,621  
Share-based compensation 7,189 8,377 13,484 17,842  
Identifiable Assets 123,427   123,427   176,447
Specialized BioTherapeutics          
Segment reporting          
Revenues   37,279   53,024  
Loss from operations (1,720,566) (1,808,652) (2,832,974) (9,166,503)  
Amortization and depreciation 1,862 3,167 3,761 6,237  
Other income, net 41,001 35,091 125,635 68,706  
Share-based compensation 28,731 18,962 58,310 44,251  
Identifiable Assets 34,272   34,272   147,784
Corporate          
Segment reporting          
Loss from operations (1,057,125) (954,483) (2,047,543) (1,911,919)  
Amortization and depreciation 6,667 7,317 13,351 14,590  
Other income, net 206,834 2,018 (6,671) 23,965  
Share-based compensation 44,701 $ 53,664 103,632 $ 82,601  
Identifiable Assets $ 29,452,590   $ 29,452,590   $ 19,567,004